Using a Heart Rate Monitor to Prevent Post-Exertional Malaise in ME/CFS & Long Covid
This article was first published on ProHealth.com and is reprinted on SolveME.org with permission of ProHealth and the author Suzan Jackson. Though originally written for individuals with ME/CFS managing PEM, members […]
Solve, BIO Online Conference Invites Biotech to Join In Fighting Long Covid
This article by Tom Popper originally appeared on Bio.com. While research into Long Covid is offering clues to causes and potential targets for treatment, defeating this debilitating condition, which impacts […]
Just released! FY23 Peer Reviewed Medical Research Program (PRMRP) Funding Opportunities for ME/CFS
At Solve M.E., our advocacy team is dedicated to opening new government funding avenues for ME/CFS, Long Covid, and post-infection disease research and care. Thanks in part to these efforts […]
Key Takeaways from the New Federal Budget
Dear advocates, allies, and friends: I’d like to take one last look back at 2022 before we leap forward into an exciting new year. Starting with the Omnibus Appropriations bill, […]
Long Covid After One Year: The Good News & the Bad News
“Mild Covid-19 disease does not lead to serious or chronic long term morbidity in the vast majority of patients” was the headline in most media coverage of an important study […]
An Evolving Landscape: Long Covid’s Impact on ME/CFS
It’s hard to believe that we’re well into the third year of the COVID-19 pandemic, which coincidentally overlaps with my time as Solve M.E.’s President and CEO. In this time […]
Letter for Medical Providers on Caring for People with Severe and Very Severe ME/CFS
Are you or a loved one bedbound or homebound as a result of severe or very severe ME/CFS, perhaps following COVID? Do you struggle to do basic activities like taking […]
Join Us For Solve M.E. Advocacy Week!
We are so excited to announce that next year’s Solve M.E. 2023 Advocacy Week will take place both virtually and in person throughout the week of April 17th to April […]
Solve M.E. Leaders Join Milken Future of Health Summit
This week, the Milken Institute hosted their annual Future of Health Summit. Solve CEO & President Oved Amitay and Solve Board Member Cynthia Adinig joined other leaders in a panel […]
Challenges in Ensuring Equity In the Study and Treatment of ME/CFS and Long Covid
Co-presented by Peter Rowe, MD (Professor of Pediatrics, Director, Johns Hopkins Children’s Center Chronic Fatigue Clinic) and Camille Broussard, MD, MPH (Assistant Professor in the Division of Adolescent and Young […]
Understanding the Biomarkers of PASC (otherwise known as Long Covid)
The RECOVER Research Review (R3) Seminar Series will host a panel discussion titled, “Understanding the Biomarkers of PASC” on Tuesday, November 8th 12:00-1:30 PM EDT featuring: Michael Peluso, MD, University […]
Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid
A decade after the U.S. Food and Drug Administration (FDA) did not approve Ampligen (rintatolimod) for the treatment of ME/CFS, this antiviral and immuno-modulator drug is getting a rare second chance. […]
